Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · see citing works

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574 · see citing works

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,345 · see citing works

Coronavirus as a possible cause of severe acute respiratory syndrome

Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916 · see citing works

Infectious Diseases

Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,755 · see citing works

Bats Are Natural Reservoirs of SARS-Like Coronaviruses

Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571 · see citing works

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477 · see citing works

Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China

Guan, Y., Zheng, B., He, Y., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S., Li, P. H., Zhang, L., Guan, Y., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,404 · see citing works

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031 · see citing works

The Genome Sequence of the SARS-Associated Coronavirus

Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,017 · see citing works

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y. P., Tsoi, H., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K., & Yuen, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,529 · see citing works

Severe acute respiratory syndrome

Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,135 · see citing works

Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2

Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S.-K., Huang, I., Xu, K., Vasilieva, N. Y., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 976 · see citing works

Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China

The Chinese SARS Molecular Epidemiology Consortium (2004) · Science · doi:10.1126/science.1092002 · Cited by 765 · see citing works

A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2

Wong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300520200 · Cited by 690 · see citing works

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

Yang, Z.-Y., Kong, W., Huang, Y., Roberts, A., Murphy, B., Subbarao, K., & Nabel, G. (2004) · Nature · doi:10.1038/nature02463 · Cited by 688 · see citing works

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human

Song, H., Tu, C., Zhang, G., Wang, S., Zheng, K. C., Lei, L., Chen, Q., Gao, Y., Zhou, H., Xiang, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409608102 · Cited by 683 · see citing works

Coronavirus Spike Proteins in Viral Entry and Pathogenesis

Gallagher, T. M., & Buchmeier, M. J. (2001) · Virology · doi:10.1006/viro.2000.0757 · Cited by 658 · see citing works

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., Tallarico, A. S. C., Olurinde, M., Choe, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307140101 · Cited by 540 · see citing works

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C. R., Xiong, H., Farmar, J. G., Debnath, A. K., Tien, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15788-7 · Cited by 503 · see citing works

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides

Bosch, B., Martina, B. E. E., van der Zee, R., Lepault, J., Haijema, B. J., Versluis, C., Heck, A. J. R., de Groot, R. J., Osterhaus, A. D. M. E., & Rottier, P. J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400576101 · Cited by 417 · see citing works

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

Bisht, H., Roberts, A., Vogel, L., Bukreyev, A. A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 415 · see citing works

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.106 · Cited by 400 · see citing works

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

Buchholz, U. J., Bukreyev, A. A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385 · see citing works

Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets

Weingartl, H. M., Czub, M., Czub, S., Neufeld, J., Marszal, P., Gren, J., Smith, G. A., Jones, S. E., Proulx, R., Deschambault, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12672-12676.2004 · Cited by 344 · see citing works

SARS-Associated Coronavirus

Holmes, K. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030078 · Cited by 330 · see citing works

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

ter Meulen, J., Bakker, A. B. H., van den Brink, E. N., Weverling, G. J., Martina, B. E. E., Haagmans, B. L., Kuiken, T., de Kruif, J., Preiser, W., Spaan, W. J. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16506-9 · Cited by 266 · see citing works

Mucosal immunisation of African green monkeys ( Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS

Bukreyev, A. A., Lamirande, E. W., Buchholz, U. J., Vogel, L., Elkins, W. R., Claire, M. S., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16501-x · Cited by 256 · see citing works

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

Yang, Z., Werner, H. C., Kong, W., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 250 · see citing works

Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor

Babcock, G. J., Esshaki, D. J., Thomas, W. D., & Ambrosino, D. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4552-4560.2004 · Cited by 239 · see citing works

Cellular entry of the SARS coronavirus

Hofmann, H., & Pöhlmann, S. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.08.008 · Cited by 238 · see citing works

Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies

He, Y., Lü, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 237 · see citing works

Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2

Moore, M. J., Dorfman, T., Li, W., Wong, S. K., Li, Y., Kuhn, J. H., Coderre, J. A., Vasilieva, N. Y., Han, Z., Greenough, T. C., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10628-10635.2004 · Cited by 236 · see citing works

SARS Vaccine Development

Jiang, S., He, Y., & Liu, S. (2005) · Emerging infectious diseases · doi:10.3201/1107.050219 · Cited by 215 · see citing works

A model of the ACE2 structure and function as a SARS-CoV receptor

Prabakaran, P., Xiao, X., & Dimitrov, D. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.081 · Cited by 209 · see citing works

Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core

Tripet, B., Howard, M. W., Jobling, M. G., Holmes, R. K., Holmes, K. V., & Hodges, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400759200 · Cited by 196 · see citing works

Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region

Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., Tian, H., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 181 · see citing works

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets

CZUB, M., WEINGARTL, H., CZUB, S., HE, R., & CAO, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.033 · Cited by 180 · see citing works

Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus

van den Brink, E. N., ter Meulen, J., Cox, F., Jongeneelen, M. A. C., Thijsse, A., Throsby, M., Marissen, W. E., Rood, P. M. L., Bakker, A. B. H., Gelderblom, H. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1635-1644.2005 · Cited by 155 · see citing works

The Secret Life of ACE2 as a Receptor for the SARS Virus

Dimitrov, D. S. (2003) · Cell · doi:10.1016/s0092-8674(03)00976-0 · Cited by 145 · see citing works

Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines

He, Y., Zhou, Y., Wu, H., Luo, B., Chen, J., Li, W., & Jiang, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4050 · Cited by 142 · see citing works

Laboratory Diagnosis of Four Recent Sporadic Cases of Community-acquired SARS, Guangdong Province, China

Liang, G., Chen, Q., Xu, J., Liu, Y., Lim, W. W. L., Peiris, M. J. S., Anderson, L. J., Ruan, L., Li, H., Kan, B., et al. (2004) · Emerging infectious diseases · doi:10.3201/eid1010.040445 · Cited by 136 · see citing works

Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing Antibodies

Zhang, H., Wang, G., Li, J., Nie, Y., Shi, X., Lian, G., Wang, W., Yin, X., Zhao, Y., Qu, X., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6938-6945.2004 · Cited by 135 · see citing works

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

He, Y., Zhou, Y., Siddiqui, P., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.052 · Cited by 129 · see citing works

Amino Acids 1055 to 1192 in the S2 Region of Severe Acute Respiratory Syndrome Coronavirus S Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents

Keng, C. T., Zhang, A., Shen, S., Lip, K.-M., Fielding, B. C., Tan, T. H. P., Chou, C.-F., Loh, C. B., Wang, S., Fu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3289-3296.2005 · Cited by 101 · see citing works

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

He, Y., Zhu, Q., Liu, S., Zhou, Y., Baoan, Y., Li, J., & Jiang, S. (2005) · Virology · doi:10.1016/j.virol.2005.01.034 · Cited by 100 · see citing works

Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus

Ingallinella, P., Bianchi, E., Finotto, M., Cantoni, G., Eckert, D. M., Supekar, V. M., Bruckmann, C., Carfı́, A., & Pessi, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402753101 · Cited by 84 · see citing works

Caution Urged on SARS Vaccines

Marshall, E., & Enserink, M. (2004) · Science · doi:10.1126/science.303.5660.944 · Cited by 81 · see citing works

An Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies

Zhou, T., Wang, H., Luo, D., Rowe, T., Wang, Z., Hogan, R. J., Qiu, S., Bunzel, R. J., Huang, G., Mishra, V., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7217-7226.2004 · Cited by 81 · see citing works

Virus detectives seek source of SARS in China's wild animals

Cyranoski, D., & Abbott, A. (2003) · Nature · doi:10.1038/423467a · Cited by 56 · see citing works

Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus Immunization

Kong, W., Xu, L., Stadler, K., Ulmer, J. B., Abrignani, S., Rappuoli, R., & Nabel, G. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13915-13923.2005 · Cited by 40 · see citing works

Vaccine Design for Severe Acute Respiratory Syndrome Coronavirus

He, Y., & Jiang, S. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.327 · Cited by 39 · see citing works

Elicitation of Immunity in Mice After Immunization with the S2 Subunit of the Severe Acute Respiratory Syndrome Coronavirus

Guo, Y., Sun, S., Wang, K., Zhang, S., Zhu, W., & Chen, Z. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.510 · Cited by 38 · see citing works

One Year After Outbreak, SARS Virus Yields Some Secrets

Enserink, M. (2004) · Science · doi:10.1126/science.304.5674.1097 · Cited by 24 · see citing works

BSE case rattles Canadian officials

Hoag, H. (2003) · Nature · doi:10.1038/423467b · Cited by 10 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119 · see citing works

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654 · see citing works

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,649 · see citing works

From SARS to MERS, Thrusting Coronaviruses into the Spotlight

Song, Z., Xu, Y., Bao, L., Zhang, L., Yü, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,268 · see citing works

Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

Glowacka, I., Bertram, S., Müller, M. A., Allen, P. W., Soilleux, E. J., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirß, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,109 · see citing works

Coronavirus vaccine development: from SARS and MERS to COVID-19

Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00695-2 · Cited by 461 · see citing works

Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies

Geller, C., Varbanov, M., & Duval, R. E. (2012) · Viruses · doi:10.3390/v4113044 · Cited by 433 · see citing works

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses

Wang, N., Shang, J., Jiang, S., & Du, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00298 · Cited by 424 · see citing works

The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors

Felberbaum, R. (2015) · Biotechnology Journal · doi:10.1002/biot.201400438 · Cited by 268 · see citing works

Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity

Zhu, Y., Yu, D., Yan, H., Chong, H., & He, Y. (2020) · Journal of Virology · doi:10.1128/jvi.00635-20 · Cited by 225 · see citing works

Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies

Sardar, R., Satish, D., Birla, S., & Gupta, D. K. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04658 · Cited by 182 · see citing works

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model

Du, L., Zhao, G., He, Y., Guo, Y., Zheng, B., Jiang, S., & Zhou, Y. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.031 · Cited by 182 · see citing works

Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains

Padron-Regalado, E. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00300-x · Cited by 178 · see citing works

Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs

Sekimukai, H., Iwata‐Yoshikawa, N., Fukushi, S., Tani, H., Kataoka, M., Suzuki, T., Hasegawa, H., Niikura, K., Arai, K., & Nagata, N. (2019) · Microbiology and Immunology · doi:10.1111/1348-0421.12754 · Cited by 168 · see citing works

The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T‐Lymphocyte Epitopes

Liu, J., Sun, Y., Qi, J., Chu, F., Wu, H., Gao, F., Li, T., Yan, J., & Gao, G. F. (2010) · The Journal of Infectious Diseases · doi:10.1086/656315 · Cited by 155 · see citing works

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19

Chen, W., Hotez, P. J., & Bottazzi, M. E. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1740560 · Cited by 140 · see citing works

Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management

Liu, M., Wang, T., Zhou, Y., Zhao, Y., Zhang, Y., & Li, J. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0003 · Cited by 136 · see citing works

Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity

Du, L., Kao, R. Y. T., Zhou, Y., He, Y., Zhao, G., Wong, C., Jiang, S., Yuen, K., Jin, D., & Zheng, B.-J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.092 · Cited by 132 · see citing works

Insect cell technology is a versatile and robust vaccine manufacturing platform

Mena, J. A., & Kamen, A. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.24 · Cited by 122 · see citing works

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2

Tai, W., Zhang, X., He, Y., Jiang, S., & Du, L. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104820 · Cited by 116 · see citing works

Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach

Ahammad, I., & Lira, S. S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.213 · Cited by 112 · see citing works

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

Liu, Z., Zhou, J., Xu, W., Deng, W., Wang, Y., Wang, M., Wang, Q., Hsieh, M. K., Dong, J., Wang, X., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00612-2 · Cited by 108 · see citing works

SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen

Wang, Y., Wang, L., Cao, H., & Liu, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26320 · Cited by 93 · see citing works

Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection

Du, L., Zhao, G., Lin, Y., Chan, C. C. S., He, Y., Jiang, S., Wu, C. Y., Jin, D., Yuen, K., Zhou, Y., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.025 · Cited by 86 · see citing works

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV

Lokugamage, K. G., Iwata‐Yoshikawa, N., Ito, N., Watts, D. M., Wyde, P. R., Wang, N., Newman, P. C., Tseng, C.-T. K., Peters, C. J., & Makino, S. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.11.092 · Cited by 73 · see citing works

Severe Acute Respiratory Syndrome and Coronavirus

Hui, D. S. C., & Chan, P. K. S. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.04.009 · Cited by 72 · see citing works

Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients

Cao, Z., Liu, L., Du, L., Zhang, C., Jiang, S., Li, T., & He, Y. (2010) · Virology Journal · doi:10.1186/1743-422x-7-299 · Cited by 72 · see citing works

Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects

Arashkia, A., Jalilvand, S., Mohajel, N., Afchangi, A., Azadmanesh, K., Salehi-Vaziri, ‪., Fazlalipour, M., Pouriayevali, M. H., Jalali, T., Nasab, S. D. M., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2183 · Cited by 72 · see citing works

The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review

Hou, Y., Lu, K., & Kuo, K. (2021) · Vaccines · doi:10.3390/vaccines9080885 · Cited by 69 · see citing works

Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics

Zhou, D., Tian, X., Qi, R., Peng, C., & Zhang, W. (2020) · Glycobiology · doi:10.1093/glycob/cwaa052 · Cited by 69 · see citing works

Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein

Escriou, N., Callendret, B., Lorin, V., Combredet, C., Marianneau, P., Février, M., & Tangy, F. (2014) · Virology · doi:10.1016/j.virol.2014.01.002 · Cited by 67 · see citing works

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals

Zhu, Y., Yu, D., Han, Y., Yan, H., Chong, H., Ren, L., Wang, J., Li, T., & He, Y. (2020) · Science Advances · doi:10.1126/sciadv.abc9999 · Cited by 66 · see citing works

Immune responses against severe acute respiratory syndrome coronavirus induced by virus‐like particles in mice

Lu, X., Chen, Y., Bai, B., Hu, H., Tao, L., Yang, J., Chen, J., Chen, Z., Hú, Z., & Wang, H. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02676.x · Cited by 61 · see citing works

Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells

Bai, B., Hu, Q., Hu, H., Zhou, P., Shi, Z., Meng, J., Lu, B., Huang, Y., Mao, P., & Wang, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002685 · Cited by 59 · see citing works

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Ma, C., Su, S., Wang, J., Wei, L., Du, L., & Jiang, S. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.05.004 · Cited by 52 · see citing works

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview

Machado, B. A. S., Hodel, K. V. S., Fonseca, L. M. D. S., Mascarenhas, L. A. B., Andrade, L. P. C. D. S., Rocha, V. P. C., Soares, M. B. P., Berglund, P., Duthie, M. S., Reed, S. G., et al. (2021) · Vaccines · doi:10.3390/vaccines9111345 · Cited by 52 · see citing works

Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic

Yu, M., Zhang, T., Zhang, W., Sun, Q., Li, H., & Li, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.628551 · Cited by 51 · see citing works

Protective and Pathologic Roles of the Immune Response to Mouse Hepatitis Virus Type 1: Implications for Severe Acute Respiratory Syndrome

Khanolkar, A., Hartwig, S. M., Haag, B. A., Meyerholz, D. K., Epping, L. L., Haring, J. S., Varga, S. M., & Harty, J. T. (2009) · Journal of Virology · doi:10.1128/jvi.00355-09 · Cited by 49 · see citing works

A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity

Du, L., Zhao, G., Chan, C. C. S., Li, L., He, Y., Zhou, Y., Zheng, B., & Jiang, S. (2010) · Viral Immunology · doi:10.1089/vim.2009.0090 · Cited by 47 · see citing works

Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines

Jiang, S., Lu, L., Liu, Q., Xu, W., & Du, L. (2012) · Emerging Microbes & Infections · doi:10.1038/emi.2012.1 · Cited by 40 · see citing works

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector

Sinegubova, M. V., Orlova, N. A., Kovnir, S. V., Dayanova, L. K., & Vorobiev, I. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0242890 · Cited by 38 · see citing works

Identification and Structural Characterization of a Broadly Neutralizing Antibody Targeting a Novel Conserved Epitope on the Influenza Virus H5N1 Hemagglutinin

Du, L., Jin, L., Zhao, G., Sun, S., Li, J., Yu, H., Li, Y., Zheng, B., Liddington, R., Zhou, Y., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02344-12 · Cited by 38 · see citing works

Retrospective study, full‐length genome characterization and evaluation of viral infectivity and pathogenicity of chimeric porcine deltacoronavirus detected in Vietnam

Saeng‐chuto, K., Jermsutjarit, P., Stott, C. J., Vui, D. T., Tantituvanont, A., & Nilubol, D. (2019) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13339 · Cited by 38 · see citing works

Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients

Liu, L., Xie, J., Jianpin, S., Han, Y., Zhang, C., Fan, H., Liu, Z., Qiu, Z., He, Y., & Li, T. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.560184 · Cited by 36 · see citing works

Recombinant Ov -ASP-1, a Th1-Biased Protein Adjuvant Derived from the Helminth Onchocerca volvulus , Can Directly Bind and Activate Antigen-Presenting Cells

He, Y., Barker, S. J., Macdonald, A., Yu, Y., Cao, L., Li, J., Parhar, R. S., Heck, S., Hartmann, S., Golenbock, D. T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800531 · Cited by 35 · see citing works

Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development

Khalaj‐Hedayati, A. (2020) · Journal of Immunology Research · doi:10.1155/2020/7201752 · Cited by 35 · see citing works

Food Safety and Employee Health Implications of COVID-19: A Review

Trmčić, A., Demmings, E. M., Kniel, K. E., Wiedmann, M., & Alcaine, S. D. (2021) · Journal of Food Protection · doi:10.4315/jfp-21-201 · Cited by 37 · see citing works

Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies

Targovnik, A. M., Simonin, J. A., Callum, G. J. M., Smith, I., Warlet, F. U. C., Nugnes, M. V., Miranda, M. V., & Belaich, M. N. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11615-1 · Cited by 35 · see citing works

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19

Mamedov, T., Yuksel, D., Ilgın, M., Gürbüzaslan, İ., Gulec, B., MAMMADOVA, G., Özdarendeli, A., Yetişkin, H., Kaplan, B., Pavel, S. T. I., et al. (2021) · Vaccines · doi:10.3390/vaccines9111337 · Cited by 37 · see citing works

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04045-3 · Cited by 33 · see citing works

Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay

Sunwoo, H. H., Palaniyappan, A., Ganguly, A., Bhatnagar, P. K., Das, D., El‐Kadi, A. O. S., & Suresh, M. R. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.09.006 · Cited by 31 · see citing works

Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens

Lean, F. Z. X., Lamers, M. M., Smith, S. P., Shipley, R., Schipper, D., Temperton, N. J., Haagmans, B. L., Banyard, A. C., Bewley, K. R., Carroll, M. W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78949-0 · Cited by 30 · see citing works

COVID‐19: Clinical status of vaccine development till date

Kumar, S., Basu, M., Ghosh, P., Ansari, A., & Ghosh, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15552 · Cited by 18 · see citing works

Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks

Cao, M., Su, X., & Jiang, S. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.12.010 · Cited by 27 · see citing works

Baculovirus-Infected Insect Cells Expressing Peptide-MHC Complexes Elicit Protective Antitumor Immunity

Jordan, K. R., McMahan, R. H., Oh, J. Z., Pipeling, M. R., Pardoll, D. M., Kedl, R. M., Kappler, J. W., & Slansky, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.188 · Cited by 27 · see citing works

The Epitope and Neutralization Mechanism of AVFluIgG01, a Broad-Reactive Human Monoclonal Antibody against H5N1 Influenza Virus

Cao, Z., Meng, J.-Z., Li, X., Wu, R., Huang, Y., & He, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038126 · Cited by 27 · see citing works

Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data

McMahon, A., & Robb, N. C. (2020) · JMIR Public Health and Surveillance · doi:10.2196/21168 · Cited by 28 · see citing works

Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain

Smaoui, M. R., & Yahyaoui, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-88696-5 · Cited by 23 · see citing works

Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections

Shanmugaraj, B., Siriwattananon, K., Malla, A., & Phoolcharoen, W. (2021) · Pathogens · doi:10.3390/pathogens10081051 · Cited by 23 · see citing works

Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development

Corral‐Lugo, A., López‐Siles, M., López, D., McConnell, M. J., & Martín-Galiano, A. J. (2020) · Vaccines · doi:10.3390/vaccines8030397 · Cited by 22 · see citing works

Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses

Venkataraman, S. (2022) · Vaccines · doi:10.3390/vaccines10111805 · Cited by 24 · see citing works

Application of Traditional Vaccine Development Strategies to SARS-CoV-2

Rando, H. M., Lordan, R., Lee, A. J., Naik, A. S., Wellhausen, N., Sell, E., Kolla, L., Gitter, A., Greene, C. S., Bansal, V., et al. (2023) · mSystems · doi:10.1128/msystems.00927-22 · Cited by 21 · see citing works

Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress

Kovalenko, A. O., Ryabchevskaya, E. M., Evtushenko, E. A., Nikitin, N. A., & Karpova, O. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021701 · Cited by 19 · see citing works

Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses

Johnson, B. A., Graham, R. L., & Menachery, V. D. (2017) · Virology · doi:10.1016/j.virol.2017.12.009 · Cited by 19 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro

Vishwakarma, P., Yadav, N., Rizvi, Z. A., Khan, N., Chiranjivi, A., Mani, S., Bansal, M., Dwivedi, P., Shrivastava, T., Kumar, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613045 · Cited by 17 · see citing works

Scope of Natural Plant Extract to Deactivate COVID-19Preprint

Shahid, M. A., Chowdhury, M. A., & Kashem, M. A. (2020) · doi:10.21203/rs.3.rs-19240/v1 · Cited by 18 · see citing works

Identification of a Potential mRNA‐based Vaccine Candidate against the SARS‐CoV‐2 Spike Glycoprotein: A Reverse Vaccinology Approach

Durojaye, O. A., Sedzro, D. M., Idris, M. O., Yekeen, A. A., Fadahunsi, A. A., & Alakanse, O. S. (2022) · ChemistrySelect · doi:10.1002/slct.202103903 · Cited by 16 · see citing works

Respiratory Virus Vaccines

Broadbent, A., Boonnak, K., & Subbarao, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00059-8 · Cited by 16 · see citing works

Type IVB Pilus Operon Promoter Controlling Expression of the Severe Acute Respiratory Syndrome-Associated Coronavirus Nucleocapsid Gene in Salmonella enterica Serovar Typhi Elicits Full Immune Response by Intranasal Vaccination

Luo, F., Feng, Y., Liu, M., Li, P., Pan, Q., Jeza, V. T., Xia, B., Wu, J., & Zhang, X. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00076-07 · Cited by 16 · see citing works

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development

Ilyichev, A. A., Orlova, L. A., Sharabrin, S. V., & Карпенко, Л. И. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.676 · Cited by 15 · see citing works

Development and Validation of a S1 Protein-Based ELISA for the Specific Detection of Antibodies against Equine Coronavirus

Zhao, S., Smits, C. B., Schuurman, N., Barnum, S. M., Pusterla, N., van Kuppeveld, F. J. M., Bosch, B., van Maanen, K., & Egberink, H. F. (2019) · Viruses · doi:10.3390/v11121109 · Cited by 15 · see citing works

In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses

Fard, S. N., Petrone, L., Petruccioli, E., Alonzi, T., Matusali, G., Colavita, F., Castilletti, C., Capobianchi, M. R., & Goletti, D. (2021) · BioMed Research International · doi:10.1155/2021/8856018 · Cited by 15 · see citing works

Insight into Vaccine Development for Alphacoronaviruses Based on Structural and Immunological Analyses of Spike Proteins

Shi, Y., Shi, J., Sun, L., Tan, Y., Wang, G., Guo, F., Hu, G., Fu, Y., Fu, Z. F., Xiao, S., et al. (2021) · Journal of Virology · doi:10.1128/jvi.02284-20 · Cited by 14 · see citing works

Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review 31

Levi‐Schaffer, F., & de Marco, A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15359 · Cited by 14 · see citing works

Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo

Yadav, N., Vishwakarma, P., Khatri, R., Siddqui, G., Awasthi, A., Ahmed, S., & Samal, S. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104843 · Cited by 14 · see citing works

Analysis of Codon Usage and Nucleotide Bias in Middle East Respiratory Syndrome Coronavirus Genes

Hussain, S., Shinu, P., Islam, M. M., Chohan, M. S., & Rasool, S. T. (2020) · Evolutionary Bioinformatics · doi:10.1177/1176934320918861 · Cited by 14 · see citing works

Identification of 22 N-glycosites on Spike Glycoprotein of SARS-CoV-2 and Accessible Surface Glycopeptide Motifs: Implications on Vaccination and Antibody TherapeuticsPreprint

Zhou, D., Qi, R., Zhang, W., Tian, X., & Peng, C. (2020) · Preprints.org · doi:10.20944/preprints202002.0381.v2 · Cited by 12 · see citing works

SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad

Natarelli, L., Virgili, F., & Weber, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212243 · Cited by 12 · see citing works

Misdiagnosis of SARS-CoV-2: A Critical Review of the Influence of Sampling and Clinical Detection Methods

Keaney, D., Whelan, S., Finn, K., & Lucey, B. (2021) · Medical Sciences · doi:10.3390/medsci9020036 · Cited by 12 · see citing works

Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants

Han, S., Lee, P., & Choi, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082114 · Cited by 11 · see citing works

Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19

Tohidinia, M., & Sefid, F. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104459 · Cited by 11 · see citing works

Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19

Lee, P., & Kim, D.-J. (2020) · Immune Network · doi:10.4110/in.2020.20.e28 · Cited by 12 · see citing works

Identification of a novel linear B-cell epitope in porcine deltacoronavirus nucleocapsid protein

He, W., Shi, X., Guan, H., Zou, Y., Zhang, S., Jiang, Z., & Su, S. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12348-5 · Cited by 10 · see citing works

A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission

Wu, R., Li, X., Leung, H.-C., Cao, Z., Qiu, Z., Zhou, Y., Zheng, B., & He, Y. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.03.005 · Cited by 10 · see citing works

Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro

Luan, N., Li, T., Wang, Y., Cao, H., Yin, X., Lin, K., & Liu, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.882856 · Cited by 10 · see citing works

A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge

Chen, Y., Wu, C. C., Yeo, Y., Xu, P., & Lin, T. L. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.01.009 · Cited by 10 · see citing works

SARS-CoV Spike Proteins Expressed by the Vaccinia Virus Tiantan Strain: Secreted SQ Protein Induces Robust Neutralization Antibody in Mice

Yan, K., Tan, W., Wang, H., Wang, Y., Zhang, X., Li, Y., & Ruan, L. (2009) · Viral Immunology · doi:10.1089/vim.2008.0064 · Cited by 9 · see citing works

Human Coronaviruses: Counteracting the Damage by Storm

Schoeman, D., & Fielding, B. C. (2021) · Viruses · doi:10.3390/v13081457 · Cited by 8 · see citing works

Review of Clinical Performance of Serology Based Commercial Diagnostic Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies

Deshpande, P. S., Abraham, I. E., Pitamberwale, A., & Dhote, R. H. (2022) · Viral Immunology · doi:10.1089/vim.2020.0313 · Cited by 8 · see citing works

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1 -based plasmid vectorPreprint

Sinegubova, M. V., Orlova, N. A., Kovnir, S. V., Dayanova, L. K., & Vorobiev, I. I. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.04.368092 · Cited by 8 · see citing works

Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China

Bai, Z., Li, Q., Chen, Q., Niu, C., Wei, Y., Huang, H., Zhao, W., Chen, N., Yao, X., Zhang, Q., et al. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.09.001 · Cited by 8 · see citing works

Prediction of Conserved HLA Class I and Class II Epitopes from SARS-CoV-2 Licensed Vaccines Supports T-Cell Cross-Protection against SARS-CoV-1

López, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071622 · Cited by 7 · see citing works

Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein

Zhang, S. M., Liao, Y., Neo, T. L., Lu, Y., Liu, D. X., Vahlne, A. G., & Tam, J. P. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.05.012 · Cited by 6 · see citing works

Detection of SARS-CoV-2 in tissue: the comparative roles of RT-qPCR, in situ RNA hybridization, and immunohistochemistry

McHenry, A. J., Iyer, K., Wang, J., Liu, C., & Harigopal, M. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2085508 · Cited by 6 · see citing works

Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus

Hou, Y.-X., Peng, C., Han, Z., Zhou, P., Chen, J., & Shi, Z. (2010) · Virologica Sinica · doi:10.1007/s12250-010-3096-2 · Cited by 6 · see citing works

Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families (Review)

Babaeimarzangou, S. S., Zaker, H., Soleimannezhadbari, E., Shamsi-Gamchi, N., Kazeminia, M., Tarighi, S., Seyedian, H., Tsatsakis, A. M., Spandidos, D. A., & Margina, D. M. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11741 · Cited by 5 · see citing works

Strategies for Designing Peptide Immunogens To Elicit α-Helical Conformation-Specific Antibodies Reactive with Native Proteins

Yan, Z., Hartsock, W. J., Qian, Z., Holmes, K. V., & Hodges, R. S. (2012) · ACS symposium series · doi:10.1021/bk-2012-1095.ch006 · Cited by 5 · see citing works

Generating stable chinese hamster ovary cell clones to produce a truncated SARS‐CoV spike protein for vaccine development

Lin, S., Leng, C., & Wu, S. (2010) · Biotechnology Progress · doi:10.1002/btpr.480 · Cited by 5 · see citing works

Koronaviruset – kryssimmunitet, flokkimmunitet og vaksineutvikling

Munthe, L. A. (2020) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.20.0298 · Cited by 3 · see citing works

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine

He, Y., Li, J., Du, L., Yan, X., Hu, G., Zhou, Y., & Jiang, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.054 · Cited by 62 · see citing works

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

He, Y., Zhu, Q., Liu, S., Zhou, Y., Baoan, Y., Li, J., & Jiang, S. (2005) · Virology · doi:10.1016/j.virol.2005.01.034 · Cited by 100 · see citing works

Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies

He, Y., Lü, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 237 · see citing works

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

Zhou, Z., Post, P. L., Chubet, R. G., Holtz, K., McPherson, C. E., Petrić, M., & Cox, M. M. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.059 · Cited by 89 · see citing works

Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region

Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., Tian, H., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 181 · see citing works